iguratimod

نتایج جستجو برای: iguratimod

تعداد نتایج: 69 فیلتر نتایج به سال:

A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide

Journal: :The Journal of Immunology 2013

متن کامل

Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis

Journal: :Mediators of Inflammation 2015

متن کامل

The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care

Journal: :Life 2020

متن کامل

Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study

Journal: :The Lancet Regional Health - Western Pacific 2021

متن کامل

Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4‐related diseases: A prospective clinical trial

Journal: :International Journal of Rheumatic Diseases 2019

متن کامل

A novel DMARD, Iguratimod disrupts TGF-b signaling in epithelial cells and attenuates bleomycin-induced interstitial lung disease in mice

Journal: :Proceedings for Annual Meeting of The Japanese Pharmacological Society 2018

متن کامل

Distinct from Methotrexate and Leflunomide Arthritis by Blocking IL-17 Signaling, Drug, Iguratimod, Ameliorates Murine A Novel Disease-Modifying Antirheumatic

2013

Xu Feifei Tao Yanhong Gu Xingxin Wu Yan Shen Qiong Luo Yang Sun Wen Liu Cheng Qian Biao Jin Feifei Tao Qiang Xu

متن کامل

The Research of Effects of Iguratimod(T-614) on the Apoptosis of Peripheral Blood Mononuclear Cell and TH1 in Rheumatoid Arthritis

Journal: :Value in Health 2014

متن کامل

Iguratimod, a Disease-Modifying Anti-Rheumatic Drug, Inhibits Osteoclastogenesis and Bone Resorption through Suppression of the Nuclear Factor of Activated T Cells Signaling Pathway

Journal: :Open Journal of Rheumatology and Autoimmune Diseases 2016

متن کامل

POS0664 A MULTICENTER RANDOMIZED STUDY IN RHEUMATOID ARTHRITIS TO COMPARE IGURATIMOD, METHOTREXATE, OR COMBINATION: 52 WEEK EFFICACY AND SAFETY RESULTS OF THE SMILE TRIAL

Journal: :Annals of the Rheumatic Diseases 2021

Background: Iguratimod (IGU) has demonstrated efficacy and safety for active rheumatoid arthritis (RA) patients in double-blind clinical trials China Japan as a new disease-modifying anti-rheumatic drug (DMARD). There are no studies evaluating the radiographic progression of structural joint damage IGU treatment RA using mTSS primary endpoint. Objectives: Our study was to evaluate monotherapy c...

متن کامل

1
2
3
4
5
6
7

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید